Fluorine-18-labeled benzamide analogues for imaging the σ2 receptor status of solid tumors with positron emission tomography

Journal of Medicinal Chemistry

Volumn 50, Issue 14, 2007, Pages 3194-3204

  Tu, Zhude ^a   Xu, Jinbin ^a   Jones, Lynne A ^a   Li, Shihong ^a   Dumstorff, Craig ^a   Vangveravong, Suwanna ^a   Chen, Delphine L ^a   Wheeler, Kenneth T ^b   Welch, Michael J ^a   Mach, Robert H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; FLUORINE 18; MESYLIC ACID; N [4 [6,7 DIMETHOXY 3,4 DIHYDROISOQUINOLIN 2(1H) YL]BUTYL] 2 (2 FLUOROETHOXY) 5 IODO 3 METHOXYBENZAMIDE F 18; N [4 [6,7 DIMETHOXY 3,4 DIHYDROISOQUINOLIN 2(1H) YL]BUTYL] 2 (2 FLUOROETHOXY) 5 METHYLBENZAMIDE F 18; SIGMA 1 OPIATE RECEPTOR; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BINDING AFFINITY; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; ISOTOPE LABELING; LIGAND BINDING; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SOLID TUMOR; SYNTHESIS;

ANIMALS; BENZAMIDES; BRAIN; FEMALE; FLUORINE RADIOISOTOPES; GUINEA PIGS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, SIGMA; TISSUE DISTRIBUTION;

EID: 34447511371     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0614883     Document Type: Article

References (26)

1. Walker, J. M.; Bowen, W. D.; Walker, F. O.; Matsumoto, R. E.; De Costa, B.; Rice, K. R. Sigma receptors: Biology and function. Pharmacol Rev. 1990, 42, 355-402.
2. Hellewell, S. B.; Bowen, W. D. A sigma-like binding site in rat pheochromocytoma (PC12) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that of guinea pig brain. Brain Res. 1990, 527, 244-253.
3. Quirion R.; Bowen W. D.; Itzhak Y.; et al. A proposal for the classification of sigma binding sites. Trends Pharmacol. Sci. 1992, 13, 85-86.
4. Guitart, X.; Codony, X.; Monroy, X. Sigma receptors: Biology and therapeutic potential. Psychopharmacology 2004, 174, 1920-1929.
5. Hanner, M.; Moebius, F. F.; Flandorfer, A.; Knaus, H. G.; Striessnig, J.; Kempner, E.; et al. Purification, molecular cloning, and expression of the mammalian sigmal-binding site. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 8072-8077.
6. Hellewell, S. B.; Bruce, A.; Feinstein, G.; Orringer, J.; Williams, W.; Bowen, W. D. Rat liver and kidney contain high densities of r1 and r2 receptors: Characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol., Mol. Pharmacol Sect. 1994, 268, 9-18.
7. Vilner, B. J.; John, C. S.; Bowen, W. D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 1995, 55, 408-413.
8. Bern, W. T.; Thomas, G. E.; Mammone, J. Y.; Homan, S. M.; Levy, B. K; Johnson, F. E.; et al. Overexpression of r receptors in nonneural human tumors. Cancer Res. 1991, 51, 6558-6562.
9. Vilner B. J.; Bowen W. D. Characterization of sigma-like binding properties of NB41A3, S-20Y, and N1E-115 neuroblastomas, C6 gliomas, and NG108-15 neuroblastoma-glioma hybrid cells: Further evidence for sigma-2 receptors. In Multiple sigma and PCP receptor ligands: mechanisms for neuromodulation and neuroprotection?; Kamenka, J. M., Domino, E. F., Eds.; 7 NPP Books: Ann Arbor, MI, 1992; pp 341-353.
10. Mach, R. H.; Smith, C. R.; Al Nabulsi, I.; Whirrett, B. R.; Childers, S. R.; Wheeler, K. T. Sigma-2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res. 1997, 57, 156-161.
11. Al-Nabulsi, I.; Mach, R. H.; Wang, L. M.; Wallen, C. A.; Keng, P. C.; Sten, K.; et al. Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumor cells. Br. J. Cancer 1999, 81, 925-933.
12. Wheeler, K. T.; Wang, L. M.; Wallen, C. A.; Childers, S. R.; Cline, J. M.; Keng, P. C.; et al. Sigma-2 receptors as a biomarker of proliferation in solid tumors. Br. J. Cancer 2000, 82, 1223-1232.
13. Bowen, W. D.; Bertha, C. M.; Vilner, B. J.; Rice, K. C. CB-64D and CB-184: Ligands with high σ2 receptor affinity and subtype selectivity. Eur. J. Pharmacol. 1995, 278, 257-260.
14. Bonhaus, D. W.; Loury, D. N.; Jakeman, L. B.; To, Z.; DeSouza, A.; Eglen, R. M.; et al. [3H]BIMU-1, a 5-hydroxy-tryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig brain hippocampus. J. Pharmacol. Exp. Ther. 1993, 267, 961.
15. Colabufo, N. A.; Berardi, F.; Contino, M.; Fazio, F.; Matarrese, M.; Moresco, R. M.; Niso, M.; Perrone, R.; Tortorella, V. Distribution of sigma receptors in EMT-6 cells: Preliminary biological evaluation of PB167 and potential for in-vivo PET. J. Pharm. Pharmacol. 2005, 57 (11), 1453-1459.
16. Kassiou, M.; Dannals, R. F.; Liu, X.; Wong, D. F.; Ravert, H. T.; Scheffel, U. A. Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors. Bioorg. Med. Chem. 2005, 13 (11), 3623-3626.
17. 2 activity. J. Med. Chem. 2004, 47 (9), 2308-2317.
18. Mach, R. H.; Huang, R. H.; Freeman, R. A.; Wu, L.; Blair, S.; Luedtke, R. R. Synthesis of 2-(5-bromo-2,3-dimethoxyphenyl)-5-(aminomethyl)-1H-pyrrole analogues and their binding affinities for dopamine D2, D3, and D4 receptors. Bioorg. Med. Chem. 2003, 11, 225.
19. Huang, Y.; Luedtke, R. R.; Freeman, R. A.; Wu, L. and Mach, R. H. Synthesis and structure-activity relationships of naphthamides as dopamine D3 receptor ligands. J. Med. Chem. 2001, 44, 1815.
20. Tu, Z.; Dence, C. S.; Ponde, D. E.; Jones, L.; Wheeler, K. T.; Welch, M. J.; Mach R. H. Carbon-11 labeled sigma2 receptor ligands for imaging breast cancer. Nucl. Med. Biol. 2005, 32 (5), 423-430.
21. Xu, J.; Tu, Z.; Jones, L. A.; Vangveravong, S.; Wheeler, K. T.; Mach, R. H. [3H]N-[4-(3,4-dihydro-6,7-dimethoxyisoquinolin-2(1H)-yl) butyl]-2-methoxy-5-methylbenzamide: a novel sigma-2 receptor probe. Eur. J. Pharmacol. 2005, 25 (1-3), 8-17.
22. Hou, C.; Tu, Z.; Mach, R.; Kung, H. F; Kung, M. P. Characterization of a novel iodinated sigma-2 receptor ligand as a cell proliferation marker. Nucl. Med. Biol. 2006, 33 (2), 203-209.
23. Laforest, R.; Rowland, D. J.; Welch, M. J. MicroPET imaging of non-conventional isotopes. IEEE Trans. Nucl. Sci. 2002, 49 (5), 2119-2126.
24. 50) of an enzymatic reaction. Biochem. Pharmacol. 1973, 22, 3099-3108.
25. Mach, R. H.; Huang, Y.; Buchheimer, N.; et al. [ 18F]N-(4′- fluorobenzyl)-4-(3-bromophenyl) acetamide for imaging the sigma receptor status of tumors: Comparison with [18F]FDG and [125I]-IUDR. Nucl. Med. Biol. 2001, 28, 451-458.
26. Rowland, D. J.; Tu, Z.; Xu, J.; Ponde, D.; Mach, R. H.; Welch, M. J. Synthesis and evaluation of two high-affinity 76Br-labeled sigma-2 receptor ligands. J. Nucl. Med. 2006, 47, 1041-1048.